BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36790458)

  • 1. ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution.
    Baccelli F; Leardini D; Cerasi S; Messelodi D; Bertuccio SN; Masetti R
    Ann Hematol; 2023 Apr; 102(4):699-705. PubMed ID: 36790458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia.
    Hakkarainen M; Kaaja I; Douglas SPM; Vulliamy T; Dokal I; Soulier J; Larcher L; Peffault de Latour R; Leblanc T; Sicre de Fontbrune F; Siitonen T; Lohi O; Hellström-Lindberg E; Barbany G; Tesi B; Shimamura A; Beier F; Jackson S; Kuperman AA; Falik Zaccai T; Tamary H; Mecucci C; Capolsini I; Jahnukainen K; Salmenniemi U; Niinimäki R; Varilo T; Kilpivaara O; Wartiovaara-Kautto U
    Blood; 2023 Jun; 141(23):2853-2866. PubMed ID: 36952636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow failure syndrome caused by homozygous frameshift mutation in the ERCC6L2 gene.
    Järviaho T; Halt K; Hirvikoski P; Moilanen J; Möttönen M; Niinimäki R
    Clin Genet; 2018 Feb; 93(2):392-395. PubMed ID: 28815563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment.
    Armes H; Bewicke-Copley F; Rio-Machin A; Di Bella D; Philippe C; Wozniak A; Tummala H; Wang J; Ezponda T; Prosper F; Dokal I; Vulliamy T; Kilpivaara O; Wartiovaara-Kautto U; Fitzgibbon J; Rouault-Pierre K
    Br J Haematol; 2022 Dec; 199(5):754-764. PubMed ID: 36156210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic
    Tummala H; Dokal AD; Walne A; Ellison A; Cardoso S; Amirthasigamanipillai S; Kirwan M; Browne I; Sidhu JK; Rajeeve V; Rio-Machin A; Seraihi AA; Duncombe AS; Jenner M; Smith OP; Enright H; Norton A; Aksu T; Özbek NY; Pontikos N; Cutillas P; Dokal I; Vulliamy T
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7777-7782. PubMed ID: 29987015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function.
    Tummala H; Kirwan M; Walne AJ; Hossain U; Jackson N; Pondarre C; Plagnol V; Vulliamy T; Dokal I
    Am J Hum Genet; 2014 Feb; 94(2):246-56. PubMed ID: 24507776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERCC6L2-associated inherited bone marrow failure syndrome.
    Shabanova I; Cohen E; Cada M; Vincent A; Cohn RD; Dror Y
    Mol Genet Genomic Med; 2018 May; 6(3):463-468. PubMed ID: 29633571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERCC6L2 syndrome: attack of the TP53 clones.
    Wlodarski MW
    Blood; 2023 Jun; 141(23):2788-2789. PubMed ID: 37289478
    [No Abstract]   [Full Text] [Related]  

  • 9. First description of bone marrow failure syndrome in Spain caused by mutations in the ERCC6L2 gene.
    Bandini P; Borràs N; Fernandez Mellid E; Martin-Fernandez L; Melero Valentín P; Comes N; Ramírez L; Cadahia Fernández P; Rodríguez Ruiz M; Perez Encinas MM; Vidal F; Corrales I
    Br J Haematol; 2023 Nov; 203(4):e102-e107. PubMed ID: 37696499
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
    Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
    Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
    Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
    Rosenberg PS; Alter BP; Ebell W
    Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Douglas SPM; Siipola P; Kovanen PE; Pyörälä M; Kakko S; Savolainen ER; Salmenniemi U; Orte K; Kytölä S; Pitkänen E; Porkka K; Kilpivaara O; Wartiovaara-Kautto U
    Blood; 2019 Jun; 133(25):2724-2728. PubMed ID: 30936069
    [No Abstract]   [Full Text] [Related]  

  • 14. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation.
    Tang Y; Zhou Z; Yan H; You Y
    Front Immunol; 2022; 13():810284. PubMed ID: 35185899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R
    Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi anemia is a highly penetrant cancer susceptibility syndrome.
    Dokal I
    Haematologica; 2008 Apr; 93(4):486-8. PubMed ID: 18379006
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myelodysplastic syndrome, acute leukemia and stem cell transplantation].
    Schmalzing M; Aringer M; Bornhäuser M; Atta J
    Z Rheumatol; 2017 Oct; 76(Suppl 2):26-32. PubMed ID: 29330757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.